Inadequate Uptake of USPSTF-Recommended Low Dose CT Lung Cancer Screening
1Biotheranostics, Inc/A Hologic Company, San Diego, CA, USA.
Abstract:
In 2023, Journal of Primary Care and Community Health published the results of 4 outstanding studies in which investigators aimed to explore and improve clinician and eligible individuals' knowledge of the rationale for lung cancer screening (LCS). Their results highlighted the underutilization of LCS, particularly for certain high risk populations, and the continued disparities in screening seen between groups of eligible individuals. Here, key findings from those 2023 Journal of Primary Care and Community Health reports, along with salient findings of other recent LCS reports, are discussed. The bases for the United States Preventive Task Force (USPSTF) LCS recommendations, barriers primary care providers face, the perspective of eligible individuals, importance of shared decision-making (SDM) and disparities between groups in LCS are reviewed along with potential strategies to ensure that more eligible individuals are offered LCS.
Insights
Lung cancer screening (LCS) is underutilized, especially in high-risk groups, and shows disparities. Improving knowledge and addressing barriers are key to increasing screening rates for eligible individuals.
Area of Science:
- Primary care
- Public health
- Preventive medicine
Background:
- Lung cancer screening (LCS) is recommended for high-risk individuals.
- Current LCS utilization is suboptimal, with significant disparities among eligible populations.
- Understanding barriers to LCS is crucial for improving uptake.
Purpose of the Study:
- To review recent findings on lung cancer screening (LCS).
- To explore clinician and patient knowledge regarding LCS rationale.
- To identify strategies for increasing LCS uptake and reducing disparities.
Main Methods:
- Review of 2023 studies from the Journal of Primary Care and Community Health.
- Analysis of recent reports on lung cancer screening (LCS).
- Discussion of USPSTF recommendations, provider barriers, patient perspectives, and shared decision-making (SDM).
Main Results:
- Significant underutilization of LCS noted, particularly in specific high-risk populations.
- Persistent disparities in LCS access and utilization across different demographic groups.
- Barriers exist for primary care providers and eligible individuals regarding LCS.
Conclusions:
- Improving knowledge of LCS rationale among clinicians and patients is essential.
- Addressing provider and patient barriers, alongside promoting shared decision-making (SDM), can enhance LCS rates.
- Strategies are needed to ensure equitable access to LCS for all eligible individuals.
More Related Videos
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
